SCHEMBL2004928

SCHEMBL2004928

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CCc2ccccc2Cl)no1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
CCR4 P51679 2/20 0.36
SCN1A P35498 2/20 0.36
SCN2A Q99250 2/20 0.36
SCN3A Q9NY46 2/20 0.36
DGAT1 O75907 1/20 0.35
SRC P12931 2/20 0.34
ZAP70 P43403 2/20 0.34
MC4R P32245 1/20 0.34
HTR1A P08908 2/20 0.33
HRH3 Q9Y5N1 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990054 0.92 GHSR (0.54) GHSRL3MBTL1MEN1KMT2ACCR4
SCHEMBL2007913 0.87 GHSR (0.50) GHSRL3MBTL1KMT2ACCR4SCN1A
SCHEMBL1988077 0.86 GHSR (0.55) GHSRL3MBTL1CCR4SCN1ASCN2A
SCHEMBL1991192 0.85 GHSR (0.52) GHSRKMT2ACCR4HTR1AHRH3
SCHEMBL1989861 0.85 GHSR (0.50) GHSRL3MBTL1MEN1HTTKMT2A
SCHEMBL1991288 0.85 GHSR (0.49) GHSRL3MBTL1MEN1HTTKMT2A
SCHEMBL1990394 0.85 GHSR (0.49) GHSRL3MBTL1MEN1HTTKMT2A
SCHEMBL1988473 0.84 GHSR (0.54) GHSRL3MBTL1MEN1KMT2ACCR4
SCHEMBL1994017 0.83 GHSR (0.50) GHSRMEN1KMT2ACCR4SCN1A
SCHEMBL1994348 0.83 GHSR (0.54) GHSRL3MBTL1CCR4SCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885L3MBTL1 4774/4885MEN1 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.